维普期刊资源整合服务平台（V6.5）

36篇 您的检索式：作者名="Flockhart DA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Bioavailability andefficacy of omeprazole given orally and by nasogastric tube显示文摘	Larson C Cavuto NJ Flockhart DA	1996	Dig Dis Sci1996，41，3：	1
2	Pharmacogenetic testing of CYPgC9 and VKORC1 alleles for warfarin显示文摘	Flockhart DA O'Kane D Williams MS	2008	Genet Med2008，10，2：	1
3	Implications of cyochrome P450 interactions when prescibing medication for hypertension显示文摘	Flockhart DA Tanus-Santos JE		0，，：	1
4	Pharmacogenefics in the treatment of breast cancer 显示文摘	Stearns V Davidson NE Flockhart DA	2004	Pharmacogenomics J2004，4，3：	1
5	Selection of drugs to treat gastro-oesophageal reflux disease: the role of drug interactions显示文摘	Desta Z Mahal SK	2000	Clin Pharmacokinet2000，39，4：	1
6	Induction of testosterone metabolism by esomeprazole in a eypzcip*zheterozygote 显示文摘	Rosenshein B Flockhart DA Ho H	2004	Am JMed Sci2004，327，5：	1
7	Drug interactions and the cytochrome P450 system -- the role of cytochrome P450 2C19 显示文摘	Flockhart DA	1995	Clin Pharmacokinet1995，29，1：	1
8	Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants显示文摘	Tanus-Santos JE Desai M Flockhart DA	2001	Pharmacogenetics2001，11，8：	1
9	The need for translational research on drug-drug interactions 显示文摘	Hennessy S Flockhart DA	2012	Clin Pharmacol Ther2012，91，5：	1
10	Induction of testosterone metabolism by esomeprazole in a CYP2C19 * 2 heterozygote 显示文摘	Rosenshein B Flockhart DA Ho H	2004	Am J Med Sci2004，327，5：	1
11	Predicting asparaginase associated pancreatitis 显示文摘	Knoderer HM Robarge J Flockhart DA	2007	Pediatr Blood Cancer2007，49，5：	1
12	Clinical pharmacology:blue-chip technology显示文摘	Flockhart DA Webb DJ	1998	Lancet1998，3524，：	1
13	Implications of cytochrome P450 interactions when prescribing medication for hypertention 显示文摘	Flockhart DA Tanus-Santos JE	2002	Arch lnternMed2002，162，4：	1
14	Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen 显示文摘	Lim YC Desta Z Flockhart DA	2005	Cancer Chemother Pharmacol2005，55，：	1
15	Pharmacokinetic and phar- maeodynamie consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam 显示文摘	Yuan R Flockhart DA Balian JD	1999	J Clin Pharma- col1999，39，11：	1
16	Drug interaction, cardiac toxicity, and terfenadine:from bench to dine? ]显示文摘	FLOCKHART DA	1996	J Clin Psychopharmacol1996，16，：	1
17	Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen显示文摘	Iim YC Desta Z Flockhart DA	2005	Cancer Chemother Pharmacol2005，55，47：	1
18	Induction of testosterone metabolism by esomeprazole in a CYP2C19*2 heterozygote显示文摘	Rosenshein B Flockhart DA Ho H	2004	Am J Med Sci2004，327，5：	1
19	Inhibition of Cytochrome P450 (CYP450) Isoforms by Isoniazid:Potent Inhibition of CYP2C19 and CYP3A显示文摘	SOUKHOVA NV FLOCKHART DA	2001	Antimicrob Agents Chemother2001，45，2：	1
20	Clinical significance of the cytochrome P450 2C19 genetic polymorphism显示文摘	Desta Z Zhao X Shin JG Flockhart DA	2002	Clin Phar macokinet2002，41，12：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示